Clasificar por
Keyphrases
Thyroid Tumor
100%
Metabolic Profiling
100%
Radiotherapy
75%
Tumor Tissue
62%
Lanthanide Ions
50%
Radiation-protective Agents
50%
Radioresistance
50%
Radio Optimization
50%
Differentiated Thyroid
50%
Translational Approach
50%
Nanoparticles
50%
Glioma Tumor
50%
Radiosensitivity
50%
Differentiated Thyroid Cancer
50%
Glioblastoma
50%
Untargeted Metabolomics
50%
Nanoplatform
50%
Recurrence Risk
50%
In Vitro Model
50%
Carbon Dots (C-dots)
50%
WHO CNS5
50%
Survival Curve
37%
IDH-wildtype
30%
Mass Spectrometry
25%
Metabolomics
25%
Tumor
25%
IDH mutation
20%
MGMT Promoter
20%
Prognostic Classification
12%
Liquid Nitrogen
12%
Biological Heterogeneity
12%
Radiation Dose
12%
Volume Ratio
12%
Metabolomic Strategy
12%
Atomic number
12%
Radioresistant Tumors
12%
Gd3+
12%
DeepL
12%
Benjamini-Hochberg
12%
High-risk of Recurrence
12%
Radiotherapy Treatment
12%
Organic Phosphoric Acid
12%
Yb3+
12%
Recurrence Classification
12%
Endocrine Neoplasm
12%
α-keto Acids
12%
Surgical Adjuvants
12%
American Thyroid Association
12%
Hydroxy Acids
12%
Organooxygen Compounds
12%
Biological Variability
12%
All Cancer
12%
Association Classification
12%
Nanotechnology
12%
Metabolic Footprint
12%
Geant4
12%
Brain Tumor
12%
Tissue Sampling
12%
Material Size
12%
Metabolomics Study
12%
Radiosensitization
12%
Metabolic
12%
Expression Profile
12%
Physical Parameters
12%
Patient Response
12%
Physical Simulation
12%
Translator
12%
Pyridine
12%
High Variability
12%
Clinical Outcomes
12%
Purine
12%
Pathological Characteristics
12%
Cancer Types
12%
Partial Least Squares Discriminant Analysis (PLS-DA)
12%
Healthy Tissue
12%
X-ray
12%
Genome Analysis
12%
Patient Identification
12%
Metabolic Pathway
12%
Fatty Acids
12%
Clinical Characteristics
12%
High Risk
12%
Adjuvant Therapy
12%
Diagnostic Classification
12%
Postsurgical
12%
Glial Cells
12%
High Dose
12%
Gas Chromatography
12%
Central Nervous System
12%
Coupled Mass
12%
Nanomaterials
12%
Carboxylic Acids
12%
Moderate Risk
12%
In Vitro Test
12%
Classification Tool
12%
Amino Acids
12%
Broad Adoption
10%
Resource Challenges
10%
Oligodendroglioma
10%
CDKN2A Deletion
10%
Radiology Workflow
10%
Translational Methods
10%
WHO Grade
10%
Molecular Assessment
10%
EGFR Amplification
10%
Non-canonical
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Radiosensitizing Agent
62%
Carbon Quantum Dot
50%
Lanthanide
50%
Glioblastoma
50%
Thyroid Tumor
50%
Nanoparticle
50%
Recurrent Disease
50%
Differentiated Thyroid Cancer
42%
Recurrence Risk
20%
Malignant Neoplasm
12%
Side Effect
12%
Liquid Nitrogen
12%
Intracranial Tumor
12%
Nanomaterial
12%
Carboxylate
10%
Pyridine Derivative
10%
Purine
10%
Oxoacid
10%
Hydroxyacid
10%
Phosphoric Acid
10%
Purine Derivative
10%
Fatty Acid
10%
Amino Acid
10%